Clinical Trial Update: Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and pharmacokinetics of NRX-1074 in normal healthy volunteers, sponsored by Naurex (an affiliate of Allergan plc);…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• NRX-1074 (NRX-1074)

Snippet

Sponsor: Naurex, Inc, an affiliate of Allergan plc | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED